Bioyond Robotics is redefining the future of life sciences through intelligent automation. Based in the innovation hub of Zhangjiang Science City, Shanghai, our team unites top talent from the world’s leading robotics and life sciences companies to deliver seamless, powerful automation solutions tailored for scientific and clinical laboratories.With over 200 experts, a 5000㎡ headquarters, and a portfolio boasting 110+ patents, Bioyond Robotics stands as a trusted partner to more than 1,000 clients worldwide. We design and implement solutions that make lab operations more intuitive, efficient, and scalable, supporting scientific discovery, clinical breakthroughs, and advancements across chemistry and physics.Our vision is clear: to empower scientists everywhere with automation that’s within reach, freeing their time to push the boundaries of innovation. Bioyond Robotics – because the future of life sciences is autonomous, accessible, and inspiring

PrecisionMDX, founded in May 2015 in China, is a pioneering company dedicated to conducting cutting-edge research and providing diagnostic tests for rare diseases. Our core expertise lies in the application of Next-Generation Sequencing (NGS) technologies, which have been honed over years of experience.Our primary focus is on rare diseases, a critically underserved area of healthcare. Through our advanced NGS methodologies, we have positioned ourselves at the forefront of precision medicine, enabling us to deliver accurate and timely diagnostic solutions for conditions that often go undiagnosed or misdiagnosed.By leveraging our expertise in genomics and molecular biology, PrecisionMDX is committed to making a meaningful impact on the diagnosis and treatment of rare diseases, ultimately improving the lives of patients and their families. Our dedication to innovation and excellence drives us to continually push the boundaries of diagnostic science, ensuring that our tests are not only highly reliable but also accessible to those in need.

Established in 2011, ACRObiosystems has swiftly become a global leader in producing high-quality proteins and antibodies that cater to the diverse needs of over 2,000 satisfied customers worldwide.In the United States and Canada, our products are distributed through renowned industry giants such as Fisher, VWR, and Cedarlane, showcasing the unwavering trust these industry leaders have in the exceptional quality of our proteins. Furthermore, we are proud to serve as an OEM partner for a prominent brand, a testament to the excellence of our offerings.What sets ACRObiosystems apart is not only the exceptional quality of our products but also our unwavering commitment to affordability. We believe in delivering top-notch solutions without compromising on cost-effectiveness, making our products a compelling choice for both established institutions and emerging players in the field.As part of our growth strategy, we are actively seeking to expand our network of distributors in the USA, Canada, and South America. Partnering with ACRObiosystems means joining a company renowned for its product quality, industry partnerships, and competitive pricing.For more detailed information about our product offerings and distribution opportunities, we invite you to explore our website at www.acrobiosystems.com. To discuss potential collaborations or distributorship opportunities, please feel free to contact me via LinkedIn or through the contact methods provided on our website.Join us in our mission to advance scientific research and healthcare through the exceptional quality and affordability of ACRObiosystems' products. We look forward to connecting with you and exploring potential synergies in the near future.

In my role at BGI Health, I have been entrusted with the responsibility of spearheading business development and overseeing laboratory operations in the United States, Canada, and South America. BGI Health, a division of BGI, is dedicated to advancing the field of healthcare through innovative genomics solutions.One notable milestone in our journey was the achievement of CLIA/CAP certification for BGI@CHOP (BGI at the Children's Hospital of Philadelphia). This certification underscores our commitment to the highest standards of clinical testing and quality assurance. With this accreditation, we have been authorized to conduct clinical tests utilizing our cutting-edge Next-Generation Sequencing (NGS) platform.CLIA (Clinical Laboratory Improvement Amendments) and CAP (College of American Pathologists) certifications are the gold standards in clinical laboratory quality and competence. They reflect our unwavering dedication to ensuring the accuracy and reliability of our genetic testing services. This certification empowers us to make a significant impact in the field of clinical genomics and diagnostics.By leveraging the power of NGS and adhering to stringent regulatory standards, BGI Health is well-positioned to contribute to advancements in personalized medicine, disease diagnosis, and genomic research. Our commitment to excellence and innovation drives us to continuously explore new frontiers in genomics, ultimately benefitting patients and healthcare providers across the Americas.I invite you to learn more about our work at BGI Health and the transformative potential of our CLIA/CAP certified clinical testing services through our website and by reaching out to our team. Together, we are shaping the future of healthcare through genomics.

In my capacity as the leader of the sales and marketing team at BGI Americas, a subsidiary of BGI in the United States, I played a pivotal role in shaping the organization's growth and success. Notably, I spearheaded the establishment of two strategic entities, BGI@UC Davis (http://research.ucdavis.edu/bgi) and BGI@CHOP (http://www.research.chop.edu/cores/hts/), which have become integral to our mission and vision.One of our most significant accomplishments during this time was the rapid expansion of both our team and revenue streams. Within this remarkable period, we successfully doubled our team's size and tripled the revenue, a testament to our unwavering commitment to excellence and strategic vision.These achievements reflect the dedication and collaborative spirit of the entire BGI Americas team, and I am proud to have been part of this transformative journey.